Fredun Pharmace Standalone June 2024 Net Sales at Rs 77.54 crore, up 26.64% Y-o-Y
July 30, 2024 / 10:39 IST
Reported Standalone quarterly numbers for Fredun Pharmaceuticals Limited are:Net Sales at Rs 77.54 crore in June 2024 up 26.64% from Rs. 61.23 crore in June 2023.
Quarterly Net Profit at Rs. 4.13 crore in June 2024 up 71.96% from Rs. 2.40 crore in June 2023.
EBITDA stands at Rs. 10.48 crore in June 2024 up 37.71% from Rs. 7.61 crore in June 2023.
Fredun Pharmace EPS has increased to Rs. 8.79 in June 2024 from Rs. 5.24 in June 2023.
| Fredun Pharmace shares closed at 874.90 on July 29, 2024 (BSE) and has given 2.44% returns over the last 6 months and 4.57% over the last 12 months. |
| Fredun Pharmaceuticals Limited | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 77.54 | 117.21 | 61.23 | | Other Operating Income | -- | 0.82 | -- | | Total Income From Operations | 77.54 | 118.03 | 61.23 | | EXPENDITURE | | Consumption of Raw Materials | 57.88 | 91.82 | 34.44 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.33 | -1.90 | 10.78 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.10 | 3.90 | 2.69 | | Depreciation | 1.05 | 0.96 | 0.92 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 7.68 | 13.05 | 6.53 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 8.16 | 10.21 | 5.87 | | Other Income | 1.28 | -- | 0.82 | | P/L Before Int., Excpt. Items & Tax | 9.43 | 10.21 | 6.69 | | Interest | 3.91 | 4.37 | 2.61 | | P/L Before Exceptional Items & Tax | 5.52 | 5.84 | 4.08 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 5.52 | 5.84 | 4.08 | | Tax | 1.39 | 0.78 | 1.68 | | P/L After Tax from Ordinary Activities | 4.13 | 5.06 | 2.40 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 4.13 | 5.06 | 2.40 | | Equity Share Capital | 4.70 | 4.70 | 4.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 8.79 | 10.77 | 5.24 | | Diluted EPS | 8.79 | 10.77 | 5.24 | | EPS After Extra Ordinary | | Basic EPS | 8.79 | 10.77 | 5.24 | | Diluted EPS | 8.79 | 10.77 | 5.24 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
